| Name | Preston Drug |
|---|---|
| Organization Name | Preston Drug Inc |
| Location | 39 N 1st E, Preston, Idaho 83263 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (208) 852-1563 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
DryDiapersPlus is excited to announce that they have joined with Unique Wellness and BIOTX Ltd to provide world-class incontinence products for their customers.
Acorda Therapeutics, Inc. today announced that the Company has submitted applications to extend patent protection for AMPYRA™ (dalfampridine) Extended Release Tablets, 10 mg to the United States Patent and Trademark Office.
The Biologics Prescribers Collaborative (BPC), a project of the Alliance for Patient Access, released a new white paper, "The State of Biosimilars Policy." The paper is released in conjunction with a congressional briefing on Capitol Hill where experts will discuss the current biosimilars policy framework and its impact on prescribing, reimbursement and use.
Brightree, the leading provider of cloud-based clinical, billing and business management software solutions for the post-acute care industry, announced today the release of new Brightree Document Management capabilities that strengthen a home medical equipment (HME) provider's ability to protect reimbursements and respond more efficiently to additional documentation requests (ADRs).
Recent American Cancer Society breast cancer screening guidelines consider the anxiety created by false-positive mammography an "important but not critical outcome" when deciding who should be screened. In other words, in these guidelines, the chance that mammography will create needless cancer worry is a light thumb on the scale against breast cancer screening in some populations.
› Verified 8 days ago
| NPI Number | 1487778197 |
| Organization Name | PRESTON DRUG INC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 39 N 1st E, Preston, ID 83263 |
| Phone Number | 208-852-1563 |
News Archive
DryDiapersPlus is excited to announce that they have joined with Unique Wellness and BIOTX Ltd to provide world-class incontinence products for their customers.
Acorda Therapeutics, Inc. today announced that the Company has submitted applications to extend patent protection for AMPYRA™ (dalfampridine) Extended Release Tablets, 10 mg to the United States Patent and Trademark Office.
The Biologics Prescribers Collaborative (BPC), a project of the Alliance for Patient Access, released a new white paper, "The State of Biosimilars Policy." The paper is released in conjunction with a congressional briefing on Capitol Hill where experts will discuss the current biosimilars policy framework and its impact on prescribing, reimbursement and use.
Brightree, the leading provider of cloud-based clinical, billing and business management software solutions for the post-acute care industry, announced today the release of new Brightree Document Management capabilities that strengthen a home medical equipment (HME) provider's ability to protect reimbursements and respond more efficiently to additional documentation requests (ADRs).
Recent American Cancer Society breast cancer screening guidelines consider the anxiety created by false-positive mammography an "important but not critical outcome" when deciding who should be screened. In other words, in these guidelines, the chance that mammography will create needless cancer worry is a light thumb on the scale against breast cancer screening in some populations.
› Verified 8 days ago
News Archive
DryDiapersPlus is excited to announce that they have joined with Unique Wellness and BIOTX Ltd to provide world-class incontinence products for their customers.
Acorda Therapeutics, Inc. today announced that the Company has submitted applications to extend patent protection for AMPYRA™ (dalfampridine) Extended Release Tablets, 10 mg to the United States Patent and Trademark Office.
The Biologics Prescribers Collaborative (BPC), a project of the Alliance for Patient Access, released a new white paper, "The State of Biosimilars Policy." The paper is released in conjunction with a congressional briefing on Capitol Hill where experts will discuss the current biosimilars policy framework and its impact on prescribing, reimbursement and use.
Brightree, the leading provider of cloud-based clinical, billing and business management software solutions for the post-acute care industry, announced today the release of new Brightree Document Management capabilities that strengthen a home medical equipment (HME) provider's ability to protect reimbursements and respond more efficiently to additional documentation requests (ADRs).
Recent American Cancer Society breast cancer screening guidelines consider the anxiety created by false-positive mammography an "important but not critical outcome" when deciding who should be screened. In other words, in these guidelines, the chance that mammography will create needless cancer worry is a light thumb on the scale against breast cancer screening in some populations.
› Verified 8 days ago
Preston Drug Type: Durable Medical Equipment & Medical Supplies Supplier Location: 39 N 1st E, Preston, Idaho 83263 Phone: (208) 852-1563 | |
Eye Care For You, Llc Type: Medicare Supplier Location: 134n State St A, Preston, Idaho 83263 Phone: (208) 852-3030 |